Blog: Fresh insights driving agile collaboration

29 October 2024 Strategies for externally controlled single-arm trials En savoir plus about Strategies for externally controlled single-arm trials

27 October 2024 The rising potential of liquid biopsies in oncology En savoir plus about The rising potential of liquid biopsies in oncology

22 October 2024 Key CMC strategies for the development of cell and gene therapies En savoir plus about Key CMC strategies for the development of cell and gene therapies

21 October 2024 Dialysis trials need to be patient-centric AND dialysis-centric En savoir plus about Dialysis trials need to be patient-centric AND dialysis-centric

20 October 2024 Future directions in liquid biopsy technology En savoir plus about Future directions in liquid biopsy technology

8 October 2024 Advanced therapies: The advantage of early and frequent regulatory interactions En savoir plus about Advanced therapies: The advantage of early and frequent regulatory interactions

30 septembre 2024 Addressing challenges of data management for cosmetic, personal care and over-the-counter products En savoir plus about Addressing challenges of data management for cosmetic, personal care and over-the-counter products

23 septembre 2024 Incorporating sustainability into our clinical research operations En savoir plus about Incorporating sustainability into our clinical research operations

16 septembre 2024 Medicare drug price negotiations En savoir plus about Medicare drug price negotiations

9 septembre 2024 NICE technology appraisals of oncology treatments En savoir plus about NICE technology appraisals of oncology treatments

20 août 2024 How Fortrea helped enroll over 5 000 patients 30 days early En savoir plus about How Fortrea helped enroll over 5 000 patients 30 days early

12 août 2024 Creating a combined advanced therapy medicinal product as an SME in the EU En savoir plus about Creating a combined advanced therapy medicinal product as an SME in the EU

7 août 2024 Dr. Gillespie goes to Capitol Hill to advocate for rare kidney disease En savoir plus about Dr. Gillespie goes to Capitol Hill to advocate for rare kidney disease

31 juillet 2024 Understanding the three types of Advanced Therapy Medicinal Products (ATMPs) En savoir plus about Understanding the three types of Advanced Therapy Medicinal Products (ATMPs)

11 juillet 2024 The journey of Advanced Therapy Medicinal Product (ATMP) studies in the European Union En savoir plus about The journey of Advanced Therapy Medicinal Product (ATMP) studies in the European Union

3 juillet 2024 Clinical Development in the Precision Medicine Era En savoir plus about Clinical Development in the Precision Medicine Era

28 June 2024 Diversity Action Plans: What sponsors need to know about the latest FDA guidance En savoir plus about Diversity Action Plans: What sponsors need to know about the latest FDA guidance

24 June 2024 Enhancing endpoint protection in pain management clinical trials En savoir plus about Enhancing endpoint protection in pain management clinical trials

21 June 2024 Importance of patient perspectives in neurology clinical trials En savoir plus about Importance of patient perspectives in neurology clinical trials

11 June 2024 It's never too early for a thorough oncology product development strategy in the APAC region En savoir plus about It's never too early for a thorough oncology product development strategy in the APAC region

4 June 2024 Highlights from Asembia 2024 Summit: Key Takeaways for the Future of a Patients Journey En savoir plus about Highlights from Asembia 2024 Summit: Key Takeaways for the Future of a Patients Journey

Le 31 mai 2024 Oncology in the news: Connect with Fortrea at ASCO and access our recent webinars En savoir plus about Oncology in the news: Connect with Fortrea at ASCO and access our recent webinars

Le 31 mai 2024 Empowering young voices in pediatric clinical trials: Fortrea’s commitment to child rights and participation En savoir plus about Empowering young voices in pediatric clinical trials: Fortrea’s commitment to child rights and participation

Le 20 mai 2024 Celebrating Clinical Trials Day: A look back to move forward En savoir plus about Celebrating Clinical Trials Day: A look back to move forward

Le 15 mai 2024 Patient-Centric Solutions for Cell and Gene Therapy Trials En savoir plus about Patient-Centric Solutions for Cell and Gene Therapy Trials

Le 6 mai 2024 Scientific Research Amidst the Russia-Ukraine Conflict Fortrea's efforts in continuing scientific research and clinical trials amidst the challenges posed by the Russia-Ukraine conflict. En savoir plus about Scientific Research Amidst the Russia-Ukraine Conflict

25 April 2024 Beauty and Personal Care Research Discover Fortrea's research on beauty and personal care, focusing on sustainable trends. Read our blog for insights into the future of beauty and personal care. En savoir plus about Beauty and Personal Care Research

15 April 2024 Rare diseases: A spotlight on Gaucher disease research in India Explore Fortrea's focus on Gaucher disease research in India, addressing rare diseases with innovative treatment approaches. En savoir plus about Rare diseases: A spotlight on Gaucher disease research in India

25 March 2024 Focusing on Rare Kidney Diseases with Unique Collaborative Efforts Explore Fortrea's unique collaborative efforts in researching and addressing rare kidney diseases through advanced methodologies and patient-centric approaches. En savoir plus about Focusing on Rare Kidney Diseases with Unique Collaborative Efforts

14 March 2024 Applying an Agile Approach to Hybrid Outsourcing in Clinical Trials Learn about Fortrea's agile strategies for hybrid outsourcing in clinical trials, enhancing flexibility and efficiency. En savoir plus about Applying an Agile Approach to Hybrid Outsourcing in Clinical Trials

27 février 2024 Rare Disease Day: Celebrating Progress and Hope for the Future Join Fortrea in celebrating Rare Disease Day, highlighting progress in medical research and hope for the future. En savoir plus about Rare Disease Day: Celebrating Progress and Hope for the Future

23 février 2024 Rare Disease Clinical Trials Explore Fortrea's advancements in rare disease clinical trials and orphan drug research. Read our blog for insights into our innovative research solutions. En savoir plus about Rare Disease Clinical Trials

11 février 2024 Clinical Trials in Rare Disease Discover Fortrea's efforts in conducting clinical trials for rare diseases, aiming to develop effective treatments. En savoir plus about Clinical Trials in Rare Disease

25 janvier 2024 Continuous Glucose Monitoring Explore key considerations for using continuous glucose monitoring in diabetes management. Read Fortrea's blog for insights into CGM technology and strategies. En savoir plus about Continuous Glucose Monitoring

21 janvier 2024 Clinical Trials Regulation and CTIS Stay informed with Fortrea's blog on clinical trials regulation and regulatory updates. Prepare for upcoming changes and ensure compliance in clinical research. En savoir plus about Clinical Trials Regulation and CTIS

8 janvier 2024 Innovative Advances in Ophthalmology Medical Device Development Discover Fortrea's innovative advances in ophthalmology medical device development, enhancing eye disease treatments. En savoir plus about Innovative Advances in Ophthalmology Medical Device Development

12 December 2023 Addressing the competitive landscape for Type 2 Diabetes trials in APAC countries Fortrea addresses the challenges and strategies in conducting clinical trials for type 2 diabetes, aiming to improve treatment outcomes. En savoir plus about Addressing the competitive landscape for Type 2 Diabetes trials in APAC countries

4 December 2023 Fortrea Shanghai Office Learn about Fortrea's Shanghai office and its sustainability initiatives. Explore our efforts towards promoting a greener and sustainable future. En savoir plus about Fortrea Shanghai Office

20 November 2023 SGLT2 Inhibitors for Pediatric Patients Explore the benefits of SGLT2 inhibitors as renoprotective agents for pediatric patients. Fortrea's blog provides insights into diabetes medication and renal protection. En savoir plus about SGLT2 Inhibitors for Pediatric Patients

16 November 2023 Promoting Access to Innovative Cardiac Medical Devices Fortrea's efforts in promoting access to innovative cardiac medical devices, aiming to improve cardiovascular health through cutting-edge technology. En savoir plus about Promoting Access to Innovative Cardiac Medical Devices

27 October 2023 Key takeaways from the 2023 SCDM AC & Leadership Forum Discover the key insights and takeaways from the 2023 SCDM AC Leadership Forum, highlighting advancements and discussions in clinical data management. En savoir plus about Key takeaways from the 2023 SCDM AC & Leadership Forum

1 October 2023 Standardizing cosmetovigilence Learn about Fortrea's efforts in standardizing cosmetovigilance to ensure the safety and efficacy of cosmetic products. En savoir plus about Standardizing cosmetovigilence

28 septembre 2023 Repousser les limites des thérapies cellulaires et géniques Discover Fortrea's advancements in cell and gene therapy. Read our blog for insights into the latest breakthroughs and innovative treatments in genetic medicine. En savoir plus about Advancing cell and gene therapy frontiers

21 septembre 2023 Patient Safety in Clinical Trials Explore Fortrea's commitment to patient safety in clinical trials. Read our blog for insights and strategies to ensure patient protection and trial integrity. En savoir plus about Patient Safety in Clinical Trials

21 septembre 2023 Leveraging Precision Medicine to Advance Clinical Trials in Latin America Learn how Fortrea is advancing clinical trials in Latin America through precision medicine, enhancing treatment efficacy and patient outcomes. En savoir plus about Leveraging Precision Medicine to Advance Clinical Trials in Latin America

11 septembre 2023 Réparer, remplacer ou augmenter : Considérations clés pour les études reprises ou de transition dans les essais cliniques de dispositifs médicaux Explore Fortrea's strategies for clinical trial rescue and transition, ensuring successful outcomes and continuity. En savoir plus about Fix, replace or augment: Key considerations for rescue or transition studies in medical device clinical trials